Atropine Improves Insulin Sensitivity in Both Lean and Abdominally Obese Subjects | Zendy

Maria Svensson | Zendy; PerAnders Jansson | Zendy; A. L. Persson | Zendy; Mikaela Sjöstrand | Zendy; Jan W. Eriksson | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Atropine Improves Insulin Sensitivity in Both Lean and Abdominally Obese Subjects

Author(s) -

Maria Svensson,

PerAnders Jansson,

A. L. Persson,

Mikaela Sjöstrand,

Jan W. Eriksson

Publication year - 2011

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2011-0669

Subject(s) - physostigmine , atropine , saline , bolus (digestion) , lean body mass , medicine , endocrinology , crossover study , insulin , anesthesia , body mass index , cholinergic , body weight , placebo , alternative medicine , pathology

Dysregulated autonomic nerve activity may contribute to the development of type 2 diabetes. The aim of this study was to assess the effects of an anticholinergic agent, atropine, and a cholinergic agent, physostigmine, on insulin sensitivity in lean and abdominally obese subjects.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research